JP2020523351A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020523351A5 JP2020523351A5 JP2019568599A JP2019568599A JP2020523351A5 JP 2020523351 A5 JP2020523351 A5 JP 2020523351A5 JP 2019568599 A JP2019568599 A JP 2019568599A JP 2019568599 A JP2019568599 A JP 2019568599A JP 2020523351 A5 JP2020523351 A5 JP 2020523351A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- formula
- heterocycloalkyl
- cycloalkyl
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C*(C)C1(C)*c2nc(I)nc(N(*)**=C)c2**1 Chemical compound C*(C)C1(C)*c2nc(I)nc(N(*)**=C)c2**1 0.000 description 2
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023060086A JP7636460B2 (ja) | 2017-06-15 | 2023-04-03 | Alk2キナーゼのイミダゾール含有阻害剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762520150P | 2017-06-15 | 2017-06-15 | |
| US62/520,150 | 2017-06-15 | ||
| PCT/US2018/037503 WO2018232094A1 (en) | 2017-06-15 | 2018-06-14 | Imidazole-containing inhibitors of alk2 kinase |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023060086A Division JP7636460B2 (ja) | 2017-06-15 | 2023-04-03 | Alk2キナーゼのイミダゾール含有阻害剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020523351A JP2020523351A (ja) | 2020-08-06 |
| JP2020523351A5 true JP2020523351A5 (cg-RX-API-DMAC7.html) | 2021-07-26 |
| JP7257338B2 JP7257338B2 (ja) | 2023-04-13 |
Family
ID=64659499
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019568599A Active JP7257338B2 (ja) | 2017-06-15 | 2018-06-14 | Alk2キナーゼのイミダゾール含有阻害剤 |
| JP2023060086A Active JP7636460B2 (ja) | 2017-06-15 | 2023-04-03 | Alk2キナーゼのイミダゾール含有阻害剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023060086A Active JP7636460B2 (ja) | 2017-06-15 | 2023-04-03 | Alk2キナーゼのイミダゾール含有阻害剤 |
Country Status (20)
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2970205T (pt) | 2013-03-14 | 2019-08-26 | Tolero Pharmaceuticals Inc | Inibidores da jak2 e da alk2 e métodos para a sua utilização |
| AR112027A1 (es) | 2017-06-15 | 2019-09-11 | Biocryst Pharm Inc | Inhibidores de alk 2 quinasa que contienen imidazol |
| KR20210038906A (ko) | 2018-07-26 | 2021-04-08 | 스미토모 다이니폰 파마 온콜로지, 인크. | 비정상적 acvr1 발현과 연관된 질환을 치료하는 방법 및 그에 사용하기 위한 acvr1 억제제 |
| WO2020068729A1 (en) * | 2018-09-25 | 2020-04-02 | Incyte Corporation | Pyrazolo[4,3-d]pyrimidine compounds as alk2 abd/or fgfr modulators |
| CA3117695A1 (en) | 2018-10-26 | 2020-04-30 | Keros Therapeutics, Inc. | Crystal forms of an alk2 inhibitor |
| WO2020156445A1 (zh) | 2019-01-29 | 2020-08-06 | 山东轩竹医药科技有限公司 | 己酮糖激酶抑制剂及其用途 |
| WO2020235902A1 (ko) * | 2019-05-17 | 2020-11-26 | 주식회사 보로노이 | 헤테로고리 융합 피리미딘 유도체 및 이의 용도 |
| MX2021014273A (es) * | 2019-05-21 | 2022-01-06 | Voronoi Inc | Derivado de heteroarilo que contiene n y composicion farmaceutica que lo comprende como principio activo para la prevencion o el tratamiento de cancer. |
| MX2022001741A (es) * | 2019-08-13 | 2022-03-11 | Blueprint Medicines Corp | Sal y formas cristalinas de un inhibidor de la cinasa similar a un receptor de activina. |
| US12486274B2 (en) | 2020-01-13 | 2025-12-02 | Verge Analytics, Inc. | Substituted pyrazolo-pyrimidines and uses thereof |
| WO2021183439A1 (en) * | 2020-03-09 | 2021-09-16 | Verge Analytics, Inc. | Substituted furo[3,2-d]pyrimidines and uses thereof |
| GB202006382D0 (en) | 2020-04-30 | 2020-06-17 | Spermatech As | Use |
| US12508262B2 (en) | 2020-04-30 | 2025-12-30 | Keros Therapeutics, Inc. | Methods of using ALK2 inhibitors |
| WO2022098812A1 (en) | 2020-11-04 | 2022-05-12 | Keros Therapeutics, Inc. | Methods of treating iron overload |
| AU2021409381A1 (en) * | 2020-12-21 | 2023-08-03 | Biocryst Pharmaceuticals, Inc. | Dosing regimens for oral alk2 kinase inhibitors |
| GEAP202416425A (en) * | 2021-05-25 | 2024-02-12 | Biocryst Pharm Inc | Imidazole-containing inhibitors of alk2 kinase |
| TW202329937A (zh) | 2021-12-03 | 2023-08-01 | 美商英塞特公司 | 雙環胺ck12抑制劑 |
| US12084453B2 (en) | 2021-12-10 | 2024-09-10 | Incyte Corporation | Bicyclic amines as CDK12 inhibitors |
| EP4504341A1 (en) | 2022-04-08 | 2025-02-12 | Shy Therapeutics LLC | Compounds that interact with ras superfamily proteins for treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease |
| WO2023198114A1 (zh) * | 2022-04-13 | 2023-10-19 | 杭州邦顺制药有限公司 | Alk2激酶抑制剂 |
| WO2025240752A1 (en) * | 2024-05-15 | 2025-11-20 | University Of Miami | Mmp-13 antagonists |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4559157A (en) | 1983-04-21 | 1985-12-17 | Creative Products Resource Associates, Ltd. | Cosmetic applicator useful for skin moisturizing |
| LU84979A1 (fr) | 1983-08-30 | 1985-04-24 | Oreal | Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux |
| LU86084A1 (fr) | 1985-09-20 | 1987-04-02 | Faco Sa | Apparei de massage electrique |
| US5102417A (en) | 1985-11-07 | 1992-04-07 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
| US4800882A (en) | 1987-03-13 | 1989-01-31 | Cook Incorporated | Endovascular stent and delivery system |
| US4820508A (en) | 1987-06-23 | 1989-04-11 | Neutrogena Corporation | Skin protective composition |
| US4886062A (en) | 1987-10-19 | 1989-12-12 | Medtronic, Inc. | Intravascular radially expandable stent and method of implant |
| US4992478A (en) | 1988-04-04 | 1991-02-12 | Warner-Lambert Company | Antiinflammatory skin moisturizing composition and method of preparing same |
| US4938949A (en) | 1988-09-12 | 1990-07-03 | University Of New York | Treatment of damaged bone marrow and dosage units therefor |
| WO1990013332A1 (en) | 1989-05-11 | 1990-11-15 | Cedars-Sinai Medical Center | Stent with sustained drug delivery |
| EP0470246B1 (en) | 1990-02-28 | 1995-06-28 | Medtronic, Inc. | Intralumenal drug eluting prosthesis |
| PT100905A (pt) | 1991-09-30 | 1994-02-28 | Eisai Co Ltd | Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem |
| US5429634A (en) | 1993-09-09 | 1995-07-04 | Pdt Systems | Biogenic implant for drug delivery and method |
| US5419760A (en) | 1993-01-08 | 1995-05-30 | Pdt Systems, Inc. | Medicament dispensing stent for prevention of restenosis of a blood vessel |
| US6774278B1 (en) | 1995-06-07 | 2004-08-10 | Cook Incorporated | Coated implantable medical device |
| US6335324B1 (en) | 1998-06-25 | 2002-01-01 | Bristol-Myers Squibb Co. | Beta lactam compounds and their use as inhibitors of tryptase |
| CA2386955A1 (en) * | 1999-11-22 | 2001-05-31 | Warner-Lambert Company | Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes |
| BR0111754A (pt) | 2000-06-28 | 2003-04-29 | Astrazeneca Ab | Uso de um composto, método para inibir aurora 2 quinase em um animal de sangue quente, composto, e, composição farmacêutica |
| AU2001290912A1 (en) | 2000-09-15 | 2002-03-26 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| WO2003022214A2 (en) | 2001-09-06 | 2003-03-20 | Millennium Pharmaceuticals, Inc. | Piperazine and homopiperazine compounds |
| US6846928B2 (en) | 2002-03-15 | 2005-01-25 | Vertex Pharmaceuticals Incorporated | Compositions useful as inhibitors of protein kinases |
| US6770729B2 (en) | 2002-09-30 | 2004-08-03 | Medtronic Minimed, Inc. | Polymer compositions containing bioactive agents and methods for their use |
| WO2004081000A1 (en) | 2003-03-10 | 2004-09-23 | Astrazeneca Ab | Quinazoline derivatives |
| MY145634A (en) | 2003-12-29 | 2012-03-15 | Bristol Myers Squibb Co | Pyrrolotriazine compounds as kinase inhibitors |
| US20070244114A1 (en) | 2004-07-06 | 2007-10-18 | Myriad Genetics, Incorporated | Compounds and therapeutical use thereof |
| JP2008525422A (ja) | 2004-12-23 | 2008-07-17 | ファイザー・プロダクツ・インク | 抗癌剤として有用な複素芳香族誘導体 |
| US7572809B2 (en) | 2005-12-19 | 2009-08-11 | Hoffmann-La Roche Inc. | Isoquinoline aminopyrazole derivatives |
| SI2041138T1 (sl) * | 2006-07-07 | 2014-08-29 | Bristol-Myers Squibb Company | Pirolotriazin kinazni inhibitorji |
| US7531539B2 (en) | 2006-08-09 | 2009-05-12 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
| WO2009084695A1 (ja) | 2007-12-28 | 2009-07-09 | Carna Biosciences Inc. | 2-アミノキナゾリン誘導体 |
| JP2012504157A (ja) | 2008-09-30 | 2012-02-16 | アストラゼネカ アクチボラグ | 複素環式jakキナーゼ阻害剤 |
| CN102625804B (zh) * | 2009-06-12 | 2015-04-08 | Abivax公司 | 用于治疗aids的化合物 |
| AR079814A1 (es) * | 2009-12-31 | 2012-02-22 | Otsuka Pharma Co Ltd | Compuestos heterociclicos, composiciones farmaceuticas que los contienen y sus usos |
| US8470820B2 (en) | 2010-01-22 | 2013-06-25 | Hoffman-La Roche Inc. | Nitrogen-containing heteroaryl derivatives |
| JP6121658B2 (ja) | 2011-06-29 | 2017-04-26 | 大塚製薬株式会社 | 治療用化合物、及び関連する使用の方法 |
| US9422267B2 (en) | 2012-12-26 | 2016-08-23 | Medivation Technologies, Inc. | Fused pyrimidine compounds and use thereof |
| PT2970205T (pt) * | 2013-03-14 | 2019-08-26 | Tolero Pharmaceuticals Inc | Inibidores da jak2 e da alk2 e métodos para a sua utilização |
| GB201416754D0 (en) | 2014-09-23 | 2014-11-05 | Mission Therapeutics Ltd | Novel compounds |
| CN108239071B (zh) | 2016-12-27 | 2020-12-04 | 沈阳药科大学 | 酰胺及硫代酰胺类衍生物及其制备方法和应用 |
| AR112027A1 (es) | 2017-06-15 | 2019-09-11 | Biocryst Pharm Inc | Inhibidores de alk 2 quinasa que contienen imidazol |
-
2018
- 2018-06-13 AR ARP180101628A patent/AR112027A1/es unknown
- 2018-06-14 KR KR1020247012786A patent/KR20240063970A/ko active Pending
- 2018-06-14 IL IL271109A patent/IL271109B2/en unknown
- 2018-06-14 AU AU2018283053A patent/AU2018283053C1/en active Active
- 2018-06-14 TW TW107120504A patent/TWI833696B/zh active
- 2018-06-14 MA MA049401A patent/MA49401A/fr unknown
- 2018-06-14 CN CN201880052585.8A patent/CN110913855B/zh active Active
- 2018-06-14 WO PCT/US2018/037503 patent/WO2018232094A1/en not_active Ceased
- 2018-06-14 IL IL312670A patent/IL312670B2/en unknown
- 2018-06-14 JP JP2019568599A patent/JP7257338B2/ja active Active
- 2018-06-14 TW TW113104734A patent/TWI922889B/zh active
- 2018-06-14 EP EP18816547.6A patent/EP3638229A4/en active Pending
- 2018-06-14 MY MYPI2019007421A patent/MY204609A/en unknown
- 2018-06-14 US US16/622,816 patent/US11661426B2/en active Active
- 2018-06-14 SG SG10202112496SA patent/SG10202112496SA/en unknown
- 2018-06-14 EA EA202090052A patent/EA202090052A1/ru unknown
- 2018-06-14 CA CA3066164A patent/CA3066164A1/en active Pending
- 2018-06-14 MX MX2019015226A patent/MX2019015226A/es unknown
- 2018-06-14 KR KR1020207001054A patent/KR102659955B1/ko active Active
- 2018-06-14 BR BR112019026517-1A patent/BR112019026517A2/pt not_active Application Discontinuation
- 2018-06-14 CN CN202411166057.9A patent/CN119060060A/zh active Pending
-
2019
- 2019-12-10 PH PH12019502781A patent/PH12019502781A1/en unknown
- 2019-12-13 MX MX2023004309A patent/MX2023004309A/es unknown
- 2019-12-13 CL CL2019003669A patent/CL2019003669A1/es unknown
-
2020
- 2020-01-09 CO CONC2020/0000194A patent/CO2020000194A2/es unknown
-
2022
- 2022-08-29 AU AU2022221581A patent/AU2022221581B2/en active Active
-
2023
- 2023-02-13 US US18/168,055 patent/US12054492B2/en active Active
- 2023-04-03 JP JP2023060086A patent/JP7636460B2/ja active Active
-
2024
- 2024-04-26 US US18/647,310 patent/US20240376117A1/en active Pending